Serum Institute of India
Indian biotechnological company, vaccine manufacturer
Serum Institute of India ▸ Facts ▸ Comments ▸ News ▸ Videos
Covid: 3 vaccines at clinical trial stage in India; SII’s phase 3 trial soon
Credit: HT Digital Content Duration: 01:19Published
Covid update: 1,500 crore vaccine doses; onion export ban; Oct-Nov warning
Credit: HT Digital Content Duration: 02:18Published
Covid: Serum Institute begins human trials, 5 volunteers given first shot
Credit: HT Digital Content Duration: 02:01Published
Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR
Credit: HT Digital Content Duration: 06:42Published
COVID-19: Oxford vaccine's late stage trials to start in a week in India, says ICMR
Credit: ANI Duration: 02:24Published
COVID update: India to start late stage trials of Oxford vaccine, Shivraj tests positive again
Credit: ANI Duration: 01:38Published
You Might Like
Serum to make extra 100 million vaccine dosesSerum Institute of India will produce up to an additional 100 million COVID-19 vaccine doses for India and low and middle-income countries in 2021.The company made this announcement taking forward the..
I wish government's Covid vaccine strategy was 'Mann ki Baat': Rahul GandhiGandhi's tweet came after Prime Minister Narendra Modi aired his monthly 'Mann ki baat' programme on the All India Radio (AIR). Along with his comment, Gandhi shared a news report regarding Serum..
Serum Institute CEO lauds PM Narendra Modi's COVID-19 vaccine vision day after challenging Centre on pandemic responseIt is to be noted that the Serum Institute of India is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune.
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asksOn September 16, the Drugs Controller General of India (DCGI) allowed the Serum Institute of India (SII) to restart its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.
Phase 3 human clinical trial of Oxford vaccine begins in PuneThe phase-III human clinical trial of the Covid-19 vaccine being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began at the state-run Sassoon General Hospital..
Serum Institute of India to resume Oxford-AstraZeneca COVID-19 vaccine trials; gets DCGI nodThe Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to resume its phase two and three clinical trials for the Oxford-AstraZeneca COVID-19 vaccine.
DCGI orders Serum Institute of India to suspend recruitment for Oxford Covid-19 vaccine trials
India will have 'approved' Covid vaccine by 2021 Q1: ReportIndia is on course to have an "approved" vaccine within the first quarter of calendar year 2021 and Pune- based Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, is..
Oxford Covid vaccine trail: Vital signs of volunteers normal, says doctorTwo men, aged 32 and 48, were given the first shot of the 'Covishield' vaccine, being manufactured by Pune-based Serum Institute of India (SII), at Bharti Vidyapeeth's Medical College and Hospital on..
Covid-19 vaccine: Govt panel meets representatives of leading domestic manufacturersThe national expert group on vaccine administration for Covid-19 met representatives of leading domestic manufactures, including Serum Institute of India, Bharat Biotech and Zydus Cadila, on Monday to..
Serum Institute of India enters into partnership to accelerate manufacture, delivery of Covid vaccines for IndiaThe Serum Institute of India (SII) has entered into a new landmark partnership with Gavi, the Vaccine Alliance and the Bill and Melinda Gates Foundation, to accelerate the manufacture and delivery of..
DCGI nod to Serum Institute of India for phase 2 & 3 clinical trials of Oxford Covid-19 vaccineThe Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India for conducting phase 2 and 3 human clinical trials of the Oxford University's Covid-19 vaccine candidate in..
Coronavirus vaccine: DCGI gives nod to Serum-Oxford for phase 2, 3 clinical trials in IndiaDCGI has allowed the Serum Institute of India to conduct phase 2 and 3 human clinical trials in India on the potential COVID19 vaccine.
Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidateA subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SII) for conducting the second and third phases of..
Seven Indian pharma players race to develop Covid-19 vaccineAt least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already..
No proof MMR vaccination offers protection against Covid-19, says Serum Institute
How one Indian company could be world's door to a COVID-19 vaccineIf the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India.
Covid-19: Pune co plans to start vaccine production next monthPune-based Serum Institute, credited with affordable and innovative therapies like pneumonia and dengue monoclonal vaccines, plans to price the proposed Covid vaccine at around Rs 1,000 per dose in..